Heron Therapeutics
HRTX
#8256
Rank
A$0.36 B
Marketcap
A$1.97
Share price
0.00%
Change (1 day)
-22.07%
Change (1 year)

Revenue for Heron Therapeutics (HRTX)

Revenue in 2025 (TTM): A$0.24 Billion

According to Heron Therapeutics's latest financial reports the company's current revenue (TTM ) is A$0.23 Billion. In 2024 the company made a revenue of A$0.23 Billion an increase over the revenue in the year 2023 that were of A$0.18 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Heron Therapeutics from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$0.24 B4.43%
2024 A$0.23 B24.4%
2023 A$0.18 B17.85%
2022 A$0.15 B32.85%
2021 A$0.11 B3.32%
2020 A$0.11 B-44.71%
2019 A$0.20 B89.58%
2018 A$0.10 B179.06%
2017 A$39.4 M2121.06%
2016 A$1.77 M
2015 N/A
2014 N/A
2013 N/A
2012 N/A-100%
2011 A$0.63 M-50.81%
2010 A$1.28 M-8.76%
2009 A$1.4 M167.67%
2008 A$0.52 M
2005 A$7.36 M5.51%
2004 A$6.98 M7.05%
2003 A$6.52 M-33.54%
2002 A$9.81 M14.18%
2001 A$8.59 M42.8%
2000 A$6.02 M-81.31%
1999 A$32.2 M-0.41%
1998 A$32.33 M15.76%
1997 A$27.93 M18.04%
1996 A$23.66 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Alkermes
ALKS
A$2.29 B 880.89%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
A$1.07 B 362.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A$94.26 M-59.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.37 B 61.98%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
A$0.18 B-22.11%๐Ÿ‡บ๐Ÿ‡ธ USA